TABLE 2.
Descriptive Statistics for all Variables of Interest
| N = 2361, n (%) | |
|---|---|
| Age at Diagnosis | |
| 18–34 | 60 (2.5) |
| 35–50 | 375 (15.9) |
| 51+ | 1926 (81.6) |
| Sex | |
| Male | 1181 (50.0) |
| Female | 1180 (50.0) |
| Race | |
| White | 1958 (82.9) |
| Black | 316 (13.4) |
| Other/unknown | 87 (3.7) |
| Primary payor | |
| Not insured/unknown | 121 (5.1) |
| Private | 1103 (46.7) |
| Medicaid | 142 (6.0) |
| Medicare/other government | 995 (42.1) |
| Year of diagnosis | |
| 2004–2009 | 694 (29.4) |
| 2010–2014 | 1667 (70.6) |
| Histology | |
| Carcinoid tumor, NOS | 595 (25.2) |
| Neuroendocrine carcinoma, NOS | 1690 (71.6) |
| Atypical carcinoid tumor | 76 (3.2) |
| Primary Site | |
| Small bowel (ileum, duodenum, jejunum) | 780 (33.0) |
| Pancreas | 620 (26.3) |
| Gastric and stomach | 81 (3.4) |
| Liver | 14 (0.6) |
| Lung | 576 (24.4) |
| Kidney | 9 (0.4) |
| Prostate | 3 (0.1) |
| Rectum and colon | 278 (11.8) |
| Charlson-Deyo score | |
| 0 | 1784 (75.6) |
| 1 | 425 (18.0) |
| 2+ | 152 (6.4) |